Agfa-gevaert Nv · EURONEXT:AGFB
Agfa-gevaert Nv — Q3 2007 Earnings Presentation
6 slides from Agfa-gevaert Nv's earnings presentation, Oct 17, 2007
Slide 1: Preliminary Q3 Results 2007
Preliminary Q3 Results 2007 17 October 2007
Slide 2: Graphics: Sales (in million Euro)
Graphics: Sales (in million Euro) Total Sales -5.3% • Sales decline is leveling off (-2.6%)* 1,268 • 14 million Euro impact from higher raw 1,201 material costs in Q3 Q3 408 -2.0% 400 • Q3 EBIT margin prepress approx. 7% (+0.4.%)* • Slower market introduction in inkjet Q2 436 -5.7% (-3.4%)* 411 • Q3
Slide 3: HealthCare: Sales (in million Euro)
HealthCare: Sales (in million Euro) Total Sales -0.9% • Sales decrease due to strength of Euro with (+2.1%)* effect on price erosion 1,027 1,018 • Decline in medical film, affected by high stock Q3 338 -5.6% 319 levels at dealers (-3.0%)* • Negative currency and mix effects 0.0% • One-off effects fo
Slide 4: Specialty Products: Sales (in million Euro)
Specialty Products: Sales (in million Euro) Total Sales +11.7% (+13.1%)* 200 179 • Strong sales increase +17.0% 69 • Profitability affected by higher silver costs Q3 59 (+18.2%)* and negative mix effects +19.0% Q2 58 69 • Q3 recurring EBIT expected to be in range (+18.9%)* of 6 to 8 million Euro +0.
Slide 5: Conclusion
Conclusion • Good sales and profitability in prepress, despite Graphics headwinds such as raw material costs and price increases • Speed of inkjet roll-out overestimated, but strong belief in technology and market potential • Imaging segment important cash generator but HealthCare further alignment
Slide 6: Questions & Answers
Questions & Answers AGFA &